Rxo (RXO) Short term Debt (2022 - 2025)
Historic Short term Debt for Rxo (RXO) over the last 4 years, with Q4 2025 value amounting to $17.0 million.
- Rxo's Short term Debt changed 0.0% to $17.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $17.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $17.0 million for FY2025, which is 0.0% changed from last year.
- Per Rxo's latest filing, its Short term Debt stood at $17.0 million for Q4 2025, which was down 0.0% from $16.0 million recorded in Q3 2025.
- Rxo's 5-year Short term Debt high stood at $17.0 million for Q4 2024, and its period low was $3.0 million during Q3 2023.
- In the last 4 years, Rxo's Short term Debt had a median value of $15.5 million in 2024 and averaged $10.9 million.
- Per our database at Business Quant, Rxo's Short term Debt tumbled by 4000.0% in 2023 and then surged by 46666.67% in 2024.
- Quarter analysis of 4 years shows Rxo's Short term Debt stood at $4.0 million in 2022, then dropped by 25.0% to $3.0 million in 2023, then surged by 466.67% to $17.0 million in 2024, then changed by 0.0% to $17.0 million in 2025.
- Its last three reported values are $17.0 million in Q4 2025, $16.0 million for Q3 2025, and $16.0 million during Q2 2025.